The European Commission has published REGULATION (EU) 2021/1297 of 4 August 2021 amending Annex XVII to REACH restricting perfluorocarboxylic acids (PFCAs) containing 9 to 14 carbon atoms in the chain (C9-C14 PFCAs), their salts and substances from 23 February 2023 onwards, although some uses have been granted longer transition periods.
The decision responds to a restriction proposal submitted by German and Swedish authorities in 2017.
The main reason argued in the proposal was to prevent a switch by industry using PFOA-based substances to longer chain PFCAs (‘C9-14 chemistry’) to fulfil the same role in the end products now that the restriction for PFOA, (salts and PFOA-related substances) has become effective.
In the text of the proposal, was exposed why the use of these substances would be equally harmful to human and environmental health due to some of their properties:
Due to these properties, they are very likely to cause severe and irreversible adverse effects to the environment and to human health if their releases are not minimised.
The Committee of Risk Assessment (RAC) and the Committee for Socio Economic Analysis (SEAC) stated in their joint opinion on the restriction proposal that “Per- and polyfluoroalkyl substances (PFASs) are emerging pollutants of the 21st century.” Due to their outstanding properties - they provide water, oil, and grease repellency and are very stable − certain PFASs have been used in a variety of consumer products, as non-stick pans, cellphones and sun lotion, but their potential risk to human and environmental health is equally important.
That is why their conclusion of the Dossier Submitter’s risk assessment is that “a restriction on a Union-wide basis is justified to reduce the release of these substances into the environment and to prevent any future manufacturing, placing on the market and use”, supporting the restriction proposal.
So, taking into account the Annex XV dossier and the opinions of RAC and SEAC, the Commission finally published REGULATION (EU) 2021/1297 restricting the manufacture, use or placing on the market of linear and/or branched C9-C14 PFCAs, their salts and C9-C14 PFCA- related substances on their own, as a constituent of other substances, in mixtures and in articles, considering them “an unacceptable risk to human health and the environment”.
The application of the restriction will come into force in February 2023, but longer deferrals or overall exemptions should apply to address the cases of specific sectors.



